Option Care Health, Inc. $OPCH Shares Purchased by Teca Partners LP

Teca Partners LP grew its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 50.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 614,208 shares of the company’s stock after buying an additional 206,670 shares during the period. Option Care Health accounts for 10.8% of Teca Partners LP’s investment portfolio, making the stock its 3rd largest holding. Teca Partners LP owned about 0.39% of Option Care Health worth $17,050,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of OPCH. Invesco Ltd. increased its position in Option Care Health by 51.8% during the third quarter. Invesco Ltd. now owns 446,830 shares of the company’s stock worth $12,404,000 after buying an additional 152,467 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Option Care Health by 17.3% in the third quarter. Arrowstreet Capital Limited Partnership now owns 4,001,307 shares of the company’s stock valued at $111,076,000 after acquiring an additional 590,913 shares during the period. Aristides Capital LLC grew its position in shares of Option Care Health by 24.6% during the third quarter. Aristides Capital LLC now owns 9,574 shares of the company’s stock worth $266,000 after acquiring an additional 1,893 shares during the last quarter. UBS Group AG grew its position in shares of Option Care Health by 250.2% during the third quarter. UBS Group AG now owns 1,165,525 shares of the company’s stock worth $32,355,000 after acquiring an additional 832,720 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Option Care Health by 37.8% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 686,371 shares of the company’s stock valued at $19,054,000 after acquiring an additional 188,432 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on OPCH shares. Weiss Ratings restated a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Barrington Research upped their price objective on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. National Bank Financial set a $37.00 price objective on Option Care Health in a research report on Tuesday, January 27th. Deutsche Bank Aktiengesellschaft boosted their target price on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, December 9th. Finally, Bank of America upped their price target on Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a research note on Tuesday, December 9th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $37.27.

Option Care Health Price Performance

Shares of OPCH traded down $0.32 on Friday, reaching $29.07. The stock had a trading volume of 208,018 shares, compared to its average volume of 1,903,317. The firm has a 50-day moving average of $33.64 and a 200 day moving average of $30.70. The firm has a market capitalization of $4.55 billion, a PE ratio of 22.62, a PEG ratio of 1.67 and a beta of 0.85. Option Care Health, Inc. has a twelve month low of $24.24 and a twelve month high of $36.80. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 0.87.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Tuesday, February 24th. The company reported $0.46 EPS for the quarter, hitting analysts’ consensus estimates of $0.46. The company had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.46 billion. Option Care Health had a return on equity of 18.57% and a net margin of 3.67%.Option Care Health’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.44 earnings per share. Sell-side analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.